Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3347-3357

  Divanovic, Senad ^a   Dalli, Jesmond ^b   Jorge Nebert, Lucia F ^c   Flick, Leah M ^a   Gálvez Peralta, Marina ^c   Boespflug, Nicholas D ^a   Stankiewicz, Traci E ^a   Fitzgerald, Jonathan M ^b   Somarathna, Maheshika ^c   Karp, Christopher L ^a,d   Serhan, Charles N ^b   Nebert, Daniel W ^c  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CD59 ANTIGEN; CYTOCHROME P450 1A; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE B4; LIPID; LIPOXYGENASE; UNSPECIFIC MONOOXYGENASE; ZYMOSAN;

ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; INFLAMMATION; LIQUID CHROMATOGRAPHY; METABOLOME; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM CELL; PERITONEUM EXUDATE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; WILD TYPE;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; METABOLOME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; SIGNAL TRANSDUCTION;

EID: 84884254794     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300699     Document Type: Article

References (61)

1. Samuelsson, B. 2012. Role of basic science in the development of new medicines: examples from the eicosanoid field. J. Biol. Chem. 287: 10070-10080.
2. Campbell, E. L., C. N. Serhan, and S. P. Colgan. 2011. Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J. Immunol. 187: 3475-3481.
3. Greene, E. R., S. Huang, C. N. Serhan, and D. Panigrahy. 2011. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 96: 27-36.
4. Nebert, D. W., and C. L. Karp. 2008. Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J. Biol. Chem. 283: 36061-36065.
5. Proctor, K. G., J. R. Falck, and J. Capdevila. 1987. Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ. Res. 60: 50-59.
6. Panigrahy, D., M. L. Edin, C. R. Lee, S. Huang, D. R. Bielenberg, C. E. Butterfield, C. M. Barnés, A. Mammoto, T. Mammoto, A. Luria, et al. 2012. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J. Clin. Invest. 122: 178-191.
7. Ji, R. R., Z. Z. Xu, G. Strichartz, and C. N. Serhan. 2011. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 34: 599-609.
8. Mas, E., K. D. Croft, P. Zahra, A. Barden, and T. A. Mori. 2012. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 58: 1476-1484.
9. Serhan, C. N., G. Fredman, R. Yang, S. Karamnov, L. S. Belayev, N. G. Bazan, M. Zhu, J. W. Winkler, and N. A. Petasis. 2011. Novel proresolving aspirintriggered DHA pathway. Chem. Biol. 18: 976-987.
10. Nebert, D. W., K. Wikvall, and W. L. Miller. 2013. Human cytochromes P450 in health and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368: 20120431.
11. Nelson, D. R., D. C. Zeldin, S. M. Hoffman, L. J. Maltais, H. M. Wain, and D. W. Nebert. 2004. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14: 1-18.
12. Kühn, H., R. Wiesner, L. Alder, B. J. Fitzsimmons, J. Rokach, and A. R. Brash. 1987. Formation of lipoxin B by the pure reticulocyte lipoxygenase via sequential oxygenation of the substrate. Eur. J. Biochem. 169: 593-601.
13. Hayaishi, O., M. Katagiri, and S. Rothberg. 1955. Mechanism of the pyrocatechase reaction. J. Am. Chem. Soc. 77: 5450-5451.
14. Mason, H. S. 1957. Mechanisms of oxygen metabolism. Science 125: 1185-1188.
15. Mason, H. S., W. L. Fowlkes, and E. Peterson. 1955. Oxygen transfer and electron transport by the phenolase complex. J. Am. Chem. Soc. 77: 2914-2915.
16. Dalli, J., and C. N. Serhan. 2012. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and proresolving mediators. Blood 120: e60-e72.
17. Dragin, N., Z. Shi, R. Madan, C. L. Karp, M. A. Sartor, C. Chen, F. J. Gonzalez, and D. W. Nebert. 2008. Phenotype of the Cyp1a1/1a2/1b12/2 triple-knockout mouse. Mol. Pharmacol. 73: 1844-1856.
18. Nebert, D. W., M. Gálvez-Peralta, Z. Shi, and N. Dragin. 2010. Inbreeding and epigenetics: beneficial as well as deleterious effects. Nat. Rev. Genet. 11: 662.
19. Nebert, D. W., T. P. Dalton, G. W. Stuart, and M. J. Carvan, III. 2000. "Geneswap knock-in" cassette in mice to study allelic differences in human genes. Ann. N. Y. Acad. Sci. 919: 148-170.
20. Kolaczkowska, E., M. Chadzinska, A. Scislowska-Czarnecka, B. Plytycz, G. Opdenakker, and B. Arnold. 2006. Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis. Immunobiology 211: 137-148.
21. Oh, S. F., P. S. Pillai, A. Recchiuti, R. Yang, and C. N. Serhan. 2011. Proresolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest. 121: 569-581.
22. Lowell, C. A., L. Fumagalli, and G. Berton. 1996. Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions. J. Cell Biol. 133: 895-910.
23. Szczur, K., Y. Zheng, and M. D. Filippi. 2009. The small Rho GTPase Cdc42 regulates neutrophil polarity via CD11b integrin signaling. Blood 114: 4527-4537.
24. Sumimoto, H., and S. Minakami. 1990. Oxidation of 20-hydroxyleukotriene B4 to 20-carboxyleukotriene B4 by human neutrophil microsomes. Role of aldehyde dehydrogenase and leukotriene B4 v-hydroxylase (cytochrome P-450LTB v) in leukotriene B4 v-oxidation. J. Biol. Chem. 265: 4348-4353.
25. Serhan, C. N., and N. A. Petasis. 2011. Resolvins and protectins in inflammation resolution. Chem. Rev. 111: 5922-5943.
26. Bannenberg, G. L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K. H. Gotlinger, S. Hong, and C. N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355.
27. Chiang, N., G. Fredman, F. Bäckhed, S. F. Oh, T. Vickery, B. A. Schmidt, and C. N. Serhan. 2012. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484: 524-528.
28. Fredman, G., Y. Li, J. Dalli, N. Chiang, and C. N. Serhan. 2012. Self-limited versus delayed resolution of acute inflammation: temporal regulation of proresolving mediators and microRNA. Sci Rep 2: 639.
29. Stejskalova, L., Z. Dvorak, and P. Pavek. 2011. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr. Drug Metab. 12: 198-212.
30. Choudhary, D., I. Jansson, I. Stoilov, M. Sarfarazi, and J. B. Schenkman. 2004. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab. Dispos. 32: 840-847.
31. Lee, C A., B. P. Lawrence, N. I. Kerkvliet, and A. B. Rifkind. 1998. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes evidence for species-specific differences in responses. Toxicol. Appl. Pharmacol. 153: 1-11.
32. Ohnishi, H., N. Miyahara, and E. W. Gelfand. 2008. The role of leukotriene B(4) in allergic diseases. Allergol. Int. 57: 291-298.
33. Byrum, R. S., J. L. Goulet, J. N. Snouwaert, R. J. Griffiths, and B. H. Koller. 1999. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase-and leukotriene A4 hydrolase-deficient mice. J. Immunol. 163: 6810-6819.
34. Smith, A. G., R. Davies, T. P. Dalton, M. L. Miller, D. Judah, J. Riley, T. Gant, and D. W. Nebert. 2003. Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse. EHP Toxicogenomics 111(1T): 45-51.
35. Lindberg, R. L., and M. Negishi. 1989. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 339: 632-634.
36. Clish, C. B., B. D. Levy, N. Chiang, H. H. Tai, and C. N. Serhan. 2000. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J. Biol. Chem. 275: 25372-25380.
37. Yokomizo, T., T. Izumi, T. Takahashi, T. Kasama, Y. Kobayashi, F. Sato, Y. Taketani, and T. Shimizu. 1993. Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase. J. Biol. Chem. 268: 18128-18135.
38. Dalli, J., J. W. Winkler, R. A. Colas, H. Arnardottir, C. Y. Cheng, N. Chiang, N. A. Petasis, and C. N. Serhan. 2013. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem. Biol. 20: 188-201.
39. Serhan, C. N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176: 1848-1859.
40. Miyata, J., K. Fukunaga, R. Iwamoto, Y. Isobe, K. Niimi, R. Takamiya, T. Takihara, K. Tomomatsu, Y. Suzuki, T. Oguma, et al. 2013. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J. Allergy Clin. Immunol. 131: 353-360.
41. Kim, T. H., G. D. Kim, Y. H. Jin, Y. S. Park, and C. S. Park. 2012. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzeneinduced atopic dermatitis in NC/Nga mice. Int. Immunopharmacol. 14: 384-391.
42. Oh, S. F., M. Dona, G. Fredman, S. Krishnamoorthy, D. Irimia, and C. N. Serhan. 2012. Resolvin E2 formation and impact in inflammation resolution. J. Immunol. 188: 4527-4534.
43. Serhan, C. N. 2010. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 177: 1576-1591.
44. Schaldach, C. M., J. Riby, and L. F. Bjeldanes. 1999. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38: 7594-7600.
45. Chiaro, C. R., J. L. Morales, K. S. Prabhu, and G. H. Perdew. 2008. Leukotriene A4 metabolites are endogenous ligands for the Ah receptor. Biochemistry 47: 8445-8455.
46. Nebert, D. W., T. P. Dalton, A. B. Okey, and F. J. Gonzalez. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279: 23847-23850.
47. Buters, J. T., S. Sakai, T. Richter, T. Pineau, D. L. Alexander, U. Savas, J. Doehmer, J. M. Ward, C. R. Jefcoate, and F. J. Gonzalez. 1999. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a] anthraceneinduced lymphomas. Proc. Natl. Acad. Sci. USA 96: 1977-1982.
48. Valentine, J. L., S. S. Lee, M. J. Seaton, B. Asgharian, G. Farris, J. C. Corton, F. J. Gonzalez, and M. A. Medinsky. 1996. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141: 205-213.
49. Athirakul, K., J. A. Bradbury, J. P. Graves, L. M. DeGraff, J. Ma, Y. Zhao, J. F. Couse, R. Quigley, D. R. Harder, X. Zhao, et al. 2008. Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB J. 22: 4096-4108.
50. Nakagawa, K., V. R. Holla, Y. Wei, W. H. Wang, A. Gatica, S. Wei, S. Mei, C. M. Miller, D. R. Cha, E. Price, Jr., et al. 2006. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J. Clin. Invest. 116: 1696-1702.
51. Uno, S., T. P. Dalton, N. Dragin, C. P. Curran, S. Derkenne, M. L. Miller, H. G. Shertzer, F. J. Gonzalez, and D. W. Nebert. 2006. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol. Pharmacol. 69: 1103-1114.
52. Scheer, N., Y. Kapelyukh, L. Chatham, A. Rode, S. Buechel, and C. R.Wolf. 2012. Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines. Mol. Pharmacol. 82: 1022-1029.
53. Scheer, N., Y. Kapelyukh, J. McEwan, V. Beuger, L. A. Stanley, A. Rode, and C. R. Wolf. 2012. Modeling human cytochrome P450 2D6 metabolism and drugdrug interaction by a novel panel of knockout and humanized mouse lines. Mol. Pharmacol. 81: 63-72.
54. Hasegawa, M., Y. Kapelyukh, H. Tahara, J. Seibler, A. Rode, S. Krueger, D. N. Lee, C. R. Wolf, and N. Scheer. 2011. Quantitative prediction of human pregnane X receptor and cytochrome P450 3A4 mediated drug-drug interaction in a novel multiple humanized mouse line. Mol. Pharmacol. 80: 518-528.
55. van Herwaarden, A. E., E.Wagenaar, C.M. van der Kruijssen, R. A. vanWaterschoot, J. W. Smit, J. Y. Song, M. A. van der Valk, O. van Tellingen, J. W. van der Hoorn, H. Rosing, et al. 2007. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J. Clin. Invest. 117: 3583-3592.
56. Cheung, C., X. Ma, K. W. Krausz, S. Kimura, L. Feigenbaum, T. P. Dalton, D. W. Nebert, J. R. Idle, and F. J. Gonzalez. 2005. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem. Res. Toxicol. 18: 1471-1478.
57. Jiang, Z., T. P. Dalton, L. Jin, B. Wang, Y. Tsuneoka, H. G. Shertzer, R. Deka, and D. W. Nebert. 2005. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1-CYP1A2 locus. Hum. Mutat. 25: 196-206.
58. Shi, Z., Y. Chen, H. Dong, R. M. Amos-Kroohs, and D. W. Nebert. 2008. Generation of a 'humanized' hCYP1A1-1A2-Cyp1a1/1a2(-/-)-Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 376: 775-780.
59. Corchero, J., C. P. Granvil, T. E. Akiyama, G. P. Hayhurst, S. Pimprale, L. Feigenbaum, J. R. Idle, and F. J. Gonzalez. 2001. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4a on the disposition of debrisoquine in the mouse. Mol. Pharmacol. 60: 1260-1267.
60. Cheung, C., A. M. Yu, J. M. Ward, K. W. Krausz, T. E. Akiyama, L. Feigenbaum, and F. J. Gonzalez. 2005. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Drug Metab. Dispos. 33: 449-457.
61. Granvil, C. P., A. M. Yu, G. Elizondo, T. E. Akiyama, C. Cheung, L. Feigenbaum, K. W. Krausz, and F. J. Gonzalez. 2003. Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam. Drug Metab. Dispos. 31: 548-558.